Table 1 Characteristics of the study cohort are presented as counts (with percentage for categorical/Boolean variables) or as mean ± standard deviation (for numeric variables).
From: Association of post-COVID phenotypic manifestations with new-onset psychiatric disease
Psychiatric Diagnosis | Number of patients | Percentage of patients |
|---|---|---|
Any Psychiatric Disease | 50216 | 2.10% |
Anxiety Disorder | 25183 | 1.05% |
Depressive Disorder | 15204 | 0.64% |
Psychosis | 397 | 0.02% |
Substance Abuse | 2678 | 0.11% |
None | 2375802 | 99.36% |
HPO categories | Number of patients | Percentage of patients |
|---|---|---|
Any PASC-AM | 305360 | 12.77% |
constitutional | 98833 | 4.13% |
gastrointestinal | 87310 | 3.65% |
neurological | 86663 | 3.62% |
pulmonary | 71247 | 2.98% |
ENT | 39501 | 1.65% |
cardiovascular | 37434 | 1.57% |
endocrine | 36021 | 1.51% |
laboratory | 18130 | 0.76% |
eye | 11984 | 0.50% |
skin | 11591 | 0.48% |
immunology | 2236 | 0.09% |
Race, Ethnicity | Number of patients | Percentage of patients |
|---|---|---|
White, Non-Hispanic | 1552583 | 64.93% |
Black or African American, Non-Hispanic | 317162 | 13.26% |
Hispanic or Latino, Any Race | 290577 | 12.15% |
Unknown | 113374 | 4.74% |
Asian, Non-Hispanic | 64212 | 2.69% |
Other, Non-Hispanic | 38760 | 1.62% |
Native Hawaiian or Other Pacific Islander, Non-Hispanic | 5515 | 0.23% |
BMI (30.3 ± 9.1) | Number of patients | Percentage of patients |
|---|---|---|
BMI < 20 | 108123 | 11.32% |
20 ≤ BMI < 25 | 168792 | 17.67% |
25 ≤ BMI < 30 | 245372 | 25.68% |
30 ≤ BMI < 35 | 203517 | 21.30% |
35 ≤ BMI < 40 | 117392 | 12.29% |
BMI ≥ 40 | 112308 | 11.75% |
Hospital stay | Number of patients | Percentage of patients |
|---|---|---|
Outpatients (Length of stay = 0 days) | 2299720 | 96.18% |
Inpatients (6.1 ± 9.7) | 91286 | 3.82% |
Length of stay = 1 days | 7071 | 0.30% |
Length of stay = 2, 3 days | 28698 | 1.20% |
Length of stay = [4–7] days | 32823 | 1.37% |
Length of stay > 7 days | 22694 | 0.95% |
Comorbidities | Number of patients | Percentage of patients |
|---|---|---|
hypertension | 439125 | 18.37% |
neoplasm | 320691 | 13.41% |
non-ischemic heart disease | 242985 | 10.16% |
chronic respiratory disease | 204982 | 8.57% |
type 2 diabetes | 189753 | 7.94% |
non-hypertensive chronic kidney disease | 82864 | 3.47% |
nicotine_dependence | 75285 | 3.15% |
ischemic_heart_disease | 56842 | 2.38% |
other_liver_disease | 39212 | 1.64% |
hepatic_steatosis | 37486 | 1.57% |
hypertensive kidney disease | 36074 | 1.51% |
cerebral_infarction | 18383 | 0.77% |
malignant lymph/blood cancer | 17887 | 0.75% |
psoriasis | 16788 | 0.70% |
rheumatoid_arthritis | 16692 | 0.70% |
type 1 diabetes | 13731 | 0.57% |
hepatic_fibrosis | 9021 | 0.38% |
lupus | 6151 | 0.26% |
chronic_hepatitis | 5126 | 0.21% |
portal_hypertension | 2759 | 0.12% |
hepatic_failure | 2122 | 0.09% |
alcoholic_liver_damage | 1157 | 0.05% |
hepatic passive congestion | 509 | 0.02% |
immunosuppression | 380 | 0.02% |
Sex | Number of patients | Percentage of patients |
|---|---|---|
FEMALE | 1336507 | 55.90% |
MALE | 1053580 | 44.06% |
Other or Unknown | 919 | 0.04% |
Smoking status | Number of patients | Percentage of patients |
|---|---|---|
Non-smoker | 1120072 | 98.60% |
Current or Former | 15901 | 1.40% |
Age (40.5 ± 21.2) | Number of patients | Percentage of patients |
|---|---|---|
age < 10 | 322093 | 13.47% |
10 ≤ age ≤ 19 | 260236 | 10.88% |
20 ≤ age ≤ 29 | 328781 | 13.75% |
30 ≤ age ≤ 39 | 338379 | 14.15% |
40 ≤ age ≤ 49 | 321769 | 13.46% |
50 ≤ age ≤ 59 | 331475 | 13.86% |
60 ≤ age ≤ 69 | 271395 | 11.35% |
70 ≤ age ≤ 79 | 163010 | 6.82% |
age ≥ 80 | 53868 | 2.25% |
